Trial · NCT03057977
Adverse events1,170
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,170
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Nasopharyngitis | Infections and infestations | Placebo | 94 | 1,863 | |
| other | Nasopharyngitis | Infections and infestations | 10 mg Empagliflozin | 89 | 1,863 | |
| other | Hyperkalaemia | Metabolism and nutrition disorders | Placebo | 109 | 1,863 | |
| other | Hyperkalaemia | Metabolism and nutrition disorders | 10 mg Empagliflozin | 99 | 1,863 | |
| other | Hyperuricaemia | Metabolism and nutrition disorders | Placebo | 115 | 1,863 | |
| other | Hyperuricaemia | Metabolism and nutrition disorders | 10 mg Empagliflozin | 63 | 1,863 | |
| other | Hypotension | Vascular disorders | Placebo | 109 | 1,863 | |
| other | Hypotension | Vascular disorders | 10 mg Empagliflozin | 120 | 1,863 | |
| serious | Anaemia | Blood and lymphatic system disorders | Placebo | 6 | 1,863 | |
| serious | Anaemia | Blood and lymphatic system disorders | 10 mg Empagliflozin | 10 | 1,863 | |
| serious | Blood loss anaemia | Blood and lymphatic system disorders | Placebo | 1 | 1,863 | |
| serious | Blood loss anaemia | Blood and lymphatic system disorders | 10 mg Empagliflozin | 0 | 1,863 | |
| serious | Disseminated intravascular coagulation | Blood and lymphatic system disorders | Placebo | 0 | 1,863 | |
| serious | Disseminated intravascular coagulation | Blood and lymphatic system disorders | 10 mg Empagliflozin | 1 | 1,863 | |
| serious | Iron deficiency anaemia | Blood and lymphatic system disorders | Placebo | 0 | 1,863 | |
| serious | Iron deficiency anaemia | Blood and lymphatic system disorders | 10 mg Empagliflozin | 1 | 1,863 | |
| serious | Leukocytosis | Blood and lymphatic system disorders | Placebo | 1 | 1,863 | |
| serious | Leukocytosis | Blood and lymphatic system disorders | 10 mg Empagliflozin | 0 | 1,863 | |
| serious | Pancytopenia | Blood and lymphatic system disorders | Placebo | 1 | 1,863 | |
| serious | Pancytopenia | Blood and lymphatic system disorders | 10 mg Empagliflozin | 1 | 1,863 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03057977/events